132 related articles for article (PubMed ID: 33642390)
21. Metabolism of sphingomyelin in cultured skin fibroblasts from patients with different types of Niemann-Pick disease.
Nakashima M; Kudoh T; Sukegawa K; Maruyama K; Orii T
Tohoku J Exp Med; 1986 Apr; 148(4):365-71. PubMed ID: 3738903
[TBL] [Abstract][Full Text] [Related]
22. Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications.
Barenholz Y
Subcell Biochem; 2004; 37():167-215. PubMed ID: 15376621
[TBL] [Abstract][Full Text] [Related]
23. The presence and the role of chromatin cholesterol in rat liver regeneration.
Albi E; Magni MV
J Hepatol; 2002 Mar; 36(3):395-400. PubMed ID: 11867184
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging.
Mielke MM; Bandaru VV; Han D; An Y; Resnick SM; Ferrucci L; Haughey NJ
Aging Cell; 2015 Feb; 14(1):112-21. PubMed ID: 25345489
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
Adada M; Luberto C; Canals D
Chem Phys Lipids; 2016 May; 197():45-59. PubMed ID: 26200918
[TBL] [Abstract][Full Text] [Related]
26. Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus.
Albi E; Lazzarini R; Viola Magni M
Biochem J; 2008 Mar; 410(2):381-9. PubMed ID: 18001268
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D metabolites activate the sphingomyelin pathway and induce death of glioblastoma cells.
Magrassi L; Adorni L; Montorfano G; Rapelli S; Butti G; Berra B; Milanesi G
Acta Neurochir (Wien); 1998; 140(7):707-13; discussion 713-4. PubMed ID: 9781285
[TBL] [Abstract][Full Text] [Related]
28. Separation and characterization of the unknown phospholipid in human lens membranes.
Byrdwell WC; Borchman D; Porter RA; Taylor KG; Yappert MC
Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4333-43. PubMed ID: 8002253
[TBL] [Abstract][Full Text] [Related]
29. A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism.
He X; Chen F; McGovern MM; Schuchman EH
Anal Biochem; 2002 Jul; 306(1):115-23. PubMed ID: 12069422
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
Klar R; Levade T; Gatt S
Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
[TBL] [Abstract][Full Text] [Related]
31. The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders.
Taniguchi M; Okazaki T
Biochim Biophys Acta; 2014 May; 1841(5):692-703. PubMed ID: 24355909
[TBL] [Abstract][Full Text] [Related]
32. A nuclear magnetic resonance study of sphingomyelin in bilayer systems.
Schmidt CF; Barenholz Y; Thompson TE
Biochemistry; 1977 Jun; 16(12):2649-56. PubMed ID: 889781
[TBL] [Abstract][Full Text] [Related]
33. Role of Sphingomyelin in Alphaherpesvirus Entry.
Pastenkos G; Miller JL; Pritchard SM; Nicola AV
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541840
[TBL] [Abstract][Full Text] [Related]
34. Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to tissues from patients with Niemann-Pick disease types A and C, and Gaucher disease.
Fujiwaki T; Tasaka M; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):170-6. PubMed ID: 18502707
[TBL] [Abstract][Full Text] [Related]
35. A lipid analogue that inhibits sphingomyelin hydrolysis and synthesis, increases ceramide, and leads to cell death.
Darroch PI; Dagan A; Granot T; He X; Gatt S; Schuchman EH
J Lipid Res; 2005 Nov; 46(11):2315-24. PubMed ID: 16150832
[TBL] [Abstract][Full Text] [Related]
36. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
He X; Chen F; Gatt S; Schuchman EH
Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
[TBL] [Abstract][Full Text] [Related]
37. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis.
Schmuth M; Man MQ; Weber F; Gao W; Feingold KR; Fritsch P; Elias PM; Holleran WM
J Invest Dermatol; 2000 Sep; 115(3):459-66. PubMed ID: 10951284
[TBL] [Abstract][Full Text] [Related]
38. Lysenin, a novel sphingomyelin-specific binding protein.
Yamaji A; Sekizawa Y; Emoto K; Sakuraba H; Inoue K; Kobayashi H; Umeda M
J Biol Chem; 1998 Feb; 273(9):5300-6. PubMed ID: 9478988
[TBL] [Abstract][Full Text] [Related]
39. Pathways of sphingomyelin metabolism in cultured fibroblasts from normal and sphingomyelin lipidosis subjects.
Spence MW; Clarke JT; Cook HW
J Biol Chem; 1983 Jul; 258(14):8595-600. PubMed ID: 6863302
[TBL] [Abstract][Full Text] [Related]
40. Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin.
Sutrina SL; Chen WW
Biochim Biophys Acta; 1984 Apr; 793(2):169-79. PubMed ID: 6424713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
